{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:20:54Z","timestamp":1789662054881,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pharep.2016.12.003","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T16:05:16Z","timestamp":1483718716000},"page":"340-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning"],"prefix":"10.1007","volume":"69","author":[{"given":"Wojciech","family":"Jawie\u0144","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wilimowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"K\u0142ys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Piekoszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.12.003_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharep.2016.12.003_bib0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2016.12.003_bib0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ajem.2005.05.001","article-title":"2004 annual report of the american association of poison control centers toxic exposure surveillance system","volume":"23","author":"Watson","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.pharep.2016.12.003_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5114\/amsik.2014.50527","article-title":"Analysis of variability of concentrations of valproic acid (VPA) and its selected metabolites in the blood serum of patients treated with VPA and patients hospitalized because of VPA poisoning","volume":"4","author":"Wilimowska","year":"2014","journal-title":"Arch Forensic Med Criminol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0090-9556(24)15355-X","article-title":"Disposition of valproic acid in maternal, fetal, and newborn sheep I: Placental transfer, plasma protein binding, and clearance","volume":"28","author":"Kumar","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharep.2016.12.003_bib0035","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1517\/13543784.2013.853037","article-title":"New perspectives of valproic acid in clinical practice","volume":"22","author":"\u010cin\u010d\u00e1rov\u00e1","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharep.2016.12.003_bib0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/15563659609013799","article-title":"Delayed peak serum valproic acid in massive divalproex overdose \u2013 treatment with charcoal hemoperfusion","volume":"34","author":"Graudins","year":"1996","journal-title":"J Toxicol \u2013 Clin Toxicol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0045","series-title":"Valproic acid intoxication","author":"Burns","year":"2001"},{"key":"10.1016\/j.pharep.2016.12.003_bib0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0404.1985.tb00854.x","article-title":"Valproate: an updated review","volume":"72","author":"Gram","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pharep.2016.12.003_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1742-7843.2006.pto_417.x","article-title":"Disposition of valproic acid in self-poisoned adults","volume":"99","author":"Wilimowska","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/FTD.0000000000000100","article-title":"Population pharmacokinetics of valproic acid in adult chinese epileptic patients and its application in an individualized dosage regimen","volume":"37","author":"Lin","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharep.2016.12.003_bib0070","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/j.1552-4604.1997.tb04301.x","article-title":"Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug\u2013drug interaction and patient characteristics","volume":"37","author":"Yukawa","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00228-003-0699-7","article-title":"Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients","volume":"59","author":"El Desoky","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.jcp.0000168485.76397.5c","article-title":"Acute valproate poisoning","volume":"25","author":"Eyer","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1525-139X.2005.18106.x","article-title":"Extracorporeal management of valproic acid toxicity: a case report and review of the literature","volume":"18","author":"Al Aly","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.pharep.2016.12.003_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00007691-199906000-00005","article-title":"Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion","volume":"21","author":"Franssen","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharep.2016.12.003_bib0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1214\/aos\/1018031103","article-title":"Convergence of a stochastic approximation of the EM algorithm version","volume":"27","author":"Delyon","year":"1999","journal-title":"Ann Stat"},{"key":"10.1016\/j.pharep.2016.12.003_bib0100","unstructured":"Lixoft. Monolix Methodology. Orsay : 2014."},{"key":"10.1016\/j.pharep.2016.12.003_bib0105","series-title":"Int. Encycl. Stat. Sci","first-page":"25","article-title":"Akaike\u2019s information criterion","author":"Akaike","year":"2011"},{"key":"10.1016\/j.pharep.2016.12.003_bib0110","series-title":"Pharmacokinetic-Pharmacodynamic Modeling and Simulation","author":"Bonate","year":"2011"},{"key":"10.1016\/j.pharep.2016.12.003_bib0115","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s11095-006-9067-5","article-title":"Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide","volume":"23","author":"Brendel","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharep.2016.12.003_bib0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cmpb.2007.07.002","article-title":"A new software tool to test global identifiability of biological and physiological systems","volume":"88","author":"Bellu","year":"2007","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.pharep.2016.12.003_bib0125","unstructured":"Lixoft. Monolix Version 4.3.3. A software for the analysis of nonlinear mixed effects models. Orsay : 2014."},{"key":"10.1016\/j.pharep.2016.12.003_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","article-title":"Diagnosing model diagnostics","volume":"82","author":"Karlsson","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharep.2016.12.003_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jat\/13.4.197","article-title":"Postmortem tricyclic antidepressant concentrations: assessing cause of death using parent drug to metabolite ratio","volume":"13","author":"Apple","year":"1989","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-1211(96)00019-8","article-title":"Metabolite profiles in patients on high-dose valproate monotherapy","volume":"25","author":"Sugimoto","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2016.12.003_bib0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2125.2000.00191.x","article-title":"Apparent autoinduction of valproate \u03b2-oxidation in humans","volume":"49","author":"McLaughlin","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00613825","article-title":"Effect of activated charcoal on absorption of tolbutamide and valproate in man","volume":"24","author":"Neuvonen","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2016.12.003_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2125.1997.tb00041.x","article-title":"The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers","volume":"43","author":"AlShareef","year":"1997","journal-title":"Br J Clin Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:49Z","timestamp":1752611809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.12.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S173411401630425X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.12.003","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}